Additionally, our findings that the presence of GR itself increased cell proliferation in ER− breast cancer cells, while it had no impact on ER+ tumour cells, are in line with studies reporting an association between GR expression and prognosis/outcome [15,16,17,25]. This evidence concerns the gene NR3C1 and neoplasm.